Right on the Nose: IL-17C and Nasal Host Defense.
Right on the Nose: IL-17C and Nasal Host Defense.
复制标题
就在鼻子上:IL-17C 和鼻宿主防御。
DOI:
10.1165/rcmb.2019-0236ed
复制
发表时间:
2020
影响因子:
6.4
通讯作者:
Robinson,KevenM
中科院分区:
文献类型:
--
作者:
Zemke,AnnaC;Robinson,KevenM
Pseudomonas aeruginosa is a ubiquitous environmental organism, so common that many of us inhale this bacterium aerosolized in our daily shower. The healthy sinonasal cavity is highly resistant to infection by P. aeruginosa. When innate epithelial defenses are impaired, for example in cystic fibrosis or primary ciliary dyskinesia, P. aeruginosa is the most common organism causing chronic rhinosinusitis, a near-universal complication of both diseases. Infection of the sinonasal cavity by environmental bacterial strains may be the initiating site of respiratory infection in cystic fibrosis, and after lung transplantation, P. aeruginosa resident in the sinonasal cavity may seed the allograft. Despite the likelihood that the sinonasal cavity plays a prominent role in the establishment of chronic lower respiratory infections, relatively little is known regarding the epithelial response to gram-negative pathogens in the nose as compared with the lung. A better understanding of innate defenses against gram-negative pathogens in the sinonasal cavity would help us better target prevention and early eradication strategies for P. aeruginosa in cystic fibrosis and ciliary diseases. In this issue of the Journal, Jeon and colleagues (pp. 95–103) describe a nasal epithelial cell–P. aeruginosa coculture model (1). Using this model, they show that IL-17C is highly induced in the nasal epithelial cells by P. aeruginosa. The epithelial IL-17C response contributes to the clearance of P. aeruginosa in the model and also leads to upregulated expression of lipocalin-2 (LCN2), which sequesters some classes of bacterial siderophores, thereby decreasing bacterial iron uptake. IL-17C is a functionally distinct member of the IL-17 family, which signals in an autocrine/paracrine fashion in epithelium-rich tissue through the IL17-RA/IL17-RE receptor complex. In bronchial epithelial cells, polyinosinic: polycytidylic acid, flagellin, LPS, and intact bacteria, including P. aeruginosa, potently stimulate IL-17C production (2, 3). Increased expression of IL-17C in the bronchial epithelium is seen in a variety of disease states, including cystic fibrosis (3). Nasal epithelial production of IL-17C was previously demonstrated in a mouse model of eosinophilic rhinosinusitis, and increased IL-17C expression was seen in nasal mucosal samples from individuals with chronic rhinosinusitis compared with control subjects; however, the roles of IL-17C in nasal defense are poorly understood (4, 5). When either IL-17C or the receptor IL-17RE was silenced by Jeon and colleagues, increased growth of P. aeruginosa was seen in the coculture model. Pretreatment with recombinant IL-17C restricted P. aeruginosa growth. Interestingly, the authors show induction of LCN2 in the coculture, which is lost with silencing of IL-17C. LCN2 is produced by multiple cell types, including epithelial and myeloid cells, and is upregulated by numerous cytokines, including IL-17A, IL-22, and IL-1b; thus, additional regulatory mechanisms may exist when myeloid-derived cells are present. LCN2 has roles in different biologic processes, including host defense and iron metabolism.One main function of LCN2 is to limit bacterial access to iron. Iron is possibly the single most growth-limiting nutrient during chronic lung infections with P. aeruginosa. Thus, there is ongoing competition between the human host and the bacterium for iron, with defenses and counterdefenses on both sides of the battle. Bacterial siderophores are secreted small molecules that bind iron with high affinity and are taken back up by the bacterium. LCN2 can sequester some siderophores, thereby preventing bacterial reuptake. Siderophores are structurally diverse, and LCN2 mainly …